Instituto de Oncologia Pediatrica-IOP/GRAAC, Sao Paulo, Brazil.
PLoS One. 2013 Jul 4;8(7):e68144. doi: 10.1371/journal.pone.0068144. Print 2013.
Nosocomial bloodstream infections (nBSIs) are an important cause of morbidity and mortality and are the most frequent type of nosocomial infection in pediatric patients.
We identified the predominant pathogens and antimicrobial susceptibilities of nosocomial bloodstream isolates in pediatric patients (≤16 years of age) in the Brazilian Prospective Surveillance for nBSIs at 16 hospitals from 12 June 2007 to 31 March 2010 (Br SCOPE project).
In our study a total of 2,563 cases of nBSI were reported by hospitals participating in the Br SCOPE project. Among these, 342 clinically significant episodes of BSI were identified in pediatric patients (≤16 years of age). Ninety-six percent of BSIs were monomicrobial. Gram-negative organisms caused 49.0% of these BSIs, Gram-positive organisms caused 42.6%, and fungi caused 8.4%. The most common pathogens were Coagulase-negative staphylococci (CoNS) (21.3%), Klebsiella spp. (15.7%), Staphylococcus aureus (10.6%), and Acinetobacter spp. (9.2%). The crude mortality was 21.6% (74 of 342). Forty-five percent of nBSIs occurred in a pediatric or neonatal intensive-care unit (ICU). The most frequent underlying conditions were malignancy, in 95 patients (27.8%). Among the potential factors predisposing patients to BSI, central venous catheters were the most frequent (66.4%). Methicillin resistance was detected in 37 S. aureus isolates (27.1%). Of the Klebsiella spp. isolates, 43.2% were resistant to ceftriaxone. Of the Acinetobacter spp. and Pseudomonas aeruginosa isolates, 42.9% and 21.4%, respectively, were resistant to imipenem.
In our multicenter study, we found a high mortality and a large proportion of gram-negative bacilli with elevated levels of resistance in pediatric patients.
医院获得性血流感染(nBSI)是发病率和死亡率的重要原因,也是儿科患者中最常见的医院获得性感染类型。
我们鉴定了 2007 年 6 月 12 日至 2010 年 3 月 31 日期间,巴西 16 家医院参与的前瞻性 nBSI 监测项目(Br SCOPE 项目)中儿科患者(≤16 岁)的主要病原体和抗菌药物敏感性。
在我们的研究中,参与 Br SCOPE 项目的医院共报告了 2563 例 nBSI。其中,在儿科患者(≤16 岁)中确定了 342 例有临床意义的 BSI 病例。96%的 BSI 为单一致病菌。革兰氏阴性菌引起 49.0%的 BSI,革兰氏阳性菌引起 42.6%,真菌引起 8.4%。最常见的病原体是凝固酶阴性葡萄球菌(CoNS)(21.3%)、克雷伯菌属(15.7%)、金黄色葡萄球菌(10.6%)和不动杆菌属(9.2%)。粗死亡率为 21.6%(74/342)。45%的 nBSI 发生在儿科或新生儿重症监护病房(ICU)。最常见的基础疾病是恶性肿瘤,共 95 例(27.8%)。在导致患者发生 BSI 的潜在因素中,中心静脉导管最常见(66.4%)。37 株金黄色葡萄球菌分离株中检出耐甲氧西林(27.1%)。43.2%的克雷伯菌属对头孢曲松耐药。42.9%的不动杆菌属和 21.4%的铜绿假单胞菌对亚胺培南耐药。
在我们的多中心研究中,我们发现儿科患者死亡率较高,革兰氏阴性杆菌比例较大,耐药率较高。